Category

Alcohol Use Disorder Treatment Market Size, Share, Opportunities, And Trends By Type (Alcohol Abuse, Alcoholism (Alcohol Dependence)), By Treatment (Medication, Behavioural Therapy), And Geography - Forecasts From 2019 To 2024

Report Code:  KSI061612285 | Pages:  111

The alcohol use disorder treatment market is estimated to grow by US$6.750 billion in 2018. The growing demand for the alcohol use disorder treatment is mainly attributed to the prevalence of this disease worldwide, with the high prevalence reported in Eastern European countries, parts of South East Asia and selected countries in Americas. According to the estimates by the Institute of Medicine, in 1996 the prevalence of Fetal Alcohol Syndrome (FAS) in the United States was between 0.5 and 3.0 cases per 1,000. As per the recent reports from the specific U.S. sites, the prevalence of FAS was found to be 2 to 7 cases per 1,000, and the prevalence of Fetal Alcohol Spectrum Disorders (FASD) was estimated to be as high as 20 to 50 cases per 1,000 (Source: National Institutes of Health). Furthermore, the rising number of deaths occurring due to alcohol-related liver disease is driving the market growth during the forecast period.
 
Major industry players profiled as part of the report are Teva Pharmaceuticals USA, Inc., Adial Pharmaceuticals, Alkermes, ADDEX THERAPEUTICS, Kinnov Therapeutics, OPIANT PHARMACEUTICALS, INC, Ethypharm, and MONTISERA LTD.
 
Segmentation
The alcohol use disorder treatment market has been analyzed through following segments:
 
By Type
Alcohol Abuse
Alcoholism (Alcohol dependence)
 
By Treatment
Medication
Behavioural Therapy
 
By Geography
North America
USA
Canada
Mexico
 
South America
Brazil
Argentina
Others
 
Europe
Germany
France
United Kingdom
Spain
Others
 
Middle East and Africa
Saudi Arabia
Israel
Others
 
Asia Pacific
China
Japan
South Korea
India
Others

OUR CLIENTS